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Abstract
Tako-tsubo cardiomyopathy is characterized by chest pain, electrocardiographic
abnormalities mimicking acute myocardial infarction, akinesis or dyskinesis of
apical or mid left ventricular segments, and the absence of obstructive coronary
artery disease. Tako-tsubo cardiomyopathy is usually a potentially reversible
form of cardiac dysfunction. A careful literature search revealed no previous
report of a patient requiring mechanical circulatory support in tako-tsubo
cardiomyopathy. We report a patient with tako-tsubo cardiomyopathy, ventricular
fibrillation, and hemodynamic instability requiring a left ventricular assist device
(TandemHeart
TM) followed by improvement of left ventricular ejection fraction
to 45%. 
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Introduction
Tako-tsubo cardiomyopathy is a unique syndrome characterized by chest
pain, electrocardiographic abnormalities mimicking acute myocardial
infarction, akinesis or dyskinesis of apical or mid left ventricular segments,
and the absence of obstructive coronary artery disease. Tako-tsubo
cardiomyopathy is also called transient left ventricular apical ballooning
syndrome and is usually a potentially reversible form of cardiac dysfunction.
Initial reports of tako-tsubo cardiomyopathy did not include clinical heart
failure, ventricular fibrillation, or sudden cardiac death. Refractory
ventricular arrhythmias are now reported in up to 15% of patients with
this syndrome. A careful literature search revealed no previous report of
a patient requiring mechanical circulatory support in tako-tsubo
cardiomyopathy. We report a 51-year-old patient with tako-tsubo
cardiomyopathy, ventricular fibrillation, and hemodynamic instability
requiring a left ventricular assist device (TandemHeartTM) followed by
improvement of left ventricular ejection fraction to 45%. 
Case report
The patient is a 51-year-old woman with a past medical history of
hypertension and breast cancer, status post right mastectomy with
radiation therapy. A few days prior to presentation, the patient had
a stressful argument with family members. On the day of presentation,
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the patient developed a sudden onset of chest pain
and collapsed a few minutes later. Cardiopulmonary
resuscitation was initiated in the field. When
emergency medical services arrived, she was found
to have ventricular fibrillation and was successfully
defibrillated with 200 J. The patient was transferred
to the emergency department of a nearby
community hospital. On arrival, she was
hemodynamically stable, but had another episode
of ventricular fibrillation. The patient was again
successfully resuscitated and endotracheal
intubation with mechanical ventilation was
instituted. 
A 12-lead electrocardiogram showed diffuse ST-
segment elevations. The patient underwent
emergency cardiac catheterization which revealed
normal coronary arteries except for a 20%
nonobstructive narrowing of the distal left anterior
descending coronary artery. Ventriculography
showed severe mid and apical hypokinesis with an
estimated left ventricular ejection fraction of less
than 10%. During the procedure, the patient
became hypotensive and was started on
norepinephrine, epinephrine, and vasopressin. An
intraaortic balloon pump was inserted. The chest
roentgenogram showed bilateral pulmonary
vascular congestion and a right lower lobe opacity.
The patient was treated with an acute respiratory
distress syndrome protocol and was also started
on inhaled nitric oxide at 20,000 ppm. 
The patient was transferred to the tertiary
medical center Westchester Medical Center/New
York Medical College for further management. On
arrival, the blood pressure was 88/50 mmHg, the
pulse was regular with a rate of 102/min, and the
respiratory rate was 24/min. Physical examination
was normal except for diffuse rhonchi heard
throughout both lung fields, a regular cardiac
rhythm with a ventricular rate of 102 beats/minute,
diminished intensity of the first heart sound, and
a left ventricular third heart sound gallop heard at
the point of maximum apical impulse.
A 12-lead electrocardiogram (Figure 1) showed
sinus tachycardia and diffuse ST-segment elevations
in numerous leads. A chest roentgenogram showed
bilateral pulmonary vascular congestion and a right
lower lobe opacity. 
Normal laboratory test results included
hemoglobin, hematocrit, platelet count, random
blood glucose, serum creatinine, sodium, potassium,
chloride, calcium, magnesium, bicarbonate, total
bilirubin, alkaline phosphatase, and international
normalized ratio. The white blood cell count was
16,500 cells/mm3. Blood urea nitrogen was 
20 mg/dl. Serum aspartate aminotransferase was
212 U/l. Serum alanine aminotransferase was 
139 U/l. Serum total protein was 4.7 g/dl. Serum
albumin was 3.3 g/dl. Partial thromboplastin time
was 36 sec. Serum creatine kinase was 779 IU/l.
Serum creatine kinase MB was 43.6 IU/l. Serum
troponin I was 19.73 ng/ml. Serum lactate
dehydrogenase was 544 U/l. 
The patient was intubated with an endotracheal
tube using a 7 French catheter. A Swan-Ganz
catheter was inserted in the right internal jugular
vein. The right atrial pressure was 12 mmHg, the
right ventricular pressure was 22/10 mmHg, the
pulmonary artery pressure was 25/16 mmHg, the
pulmonary capillary wedge pressure was 8 mmHg,
the cardiac output was 2.9 l/min, the cardiac index
was 1.7 l/min/m2, the systemic vascular resistance
was 780 dyne-sec-1 cm-5, the pulmonary artery
oxygen saturation was 41%, and the arterial oxygen
saturation was 70%. The patient was treated with
inotropic and vasopressor drugs.
The day after admission, a TandemHeartTM was
implanted. Hemodynamic values were obtained
that day, 1 day after implantation, 2 days after
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implantation, and 4 days after implantation. The
right atrial pressures were 13, 10, 9, and 12 mmHg.
The right ventricular pressure (peak/mean) 
was 22/10 mmHg. The pulmonary artery pressures
(peak/mean) were 21/15, 29/18, 29/16, and 
34/24 mmHg. The pulmonary capillary wedge
pressure was 8 mmHg. The pulmonary artery
oxygen saturation values were 72%, 72%, 74%, and
73%. The cardiac outputs were 5.8, 6.4, 6.8, and 
7.0 l/min. The cardiac index values were 3.3, 3.7,
3.9, and 4.6 l/min/m2. Systemic vascular resistance
values were 857, 1048, 1028, and 747 dyne-sec-1
cm-5. Left ventricular ejection fractions were 10% ,
21%, and 42% 4 days after implantation. Tandem
flow values were 3.4, 3.6, 3.09, and 2.6 l/min. Speed
was 6350, 6950, 6350, and 5950 rotations per
minute. The patient was treated with epinephrine,
milrinone, and vasopressin on the day of
TandemHeartTM implantation and with milrinone
1 day, 2 days, and 4 days after implantation. 
The patient’s left ventricular function improved,
and the patient was weaned from the use of
inotropic and vasopressor agents. After 5 days, the
Tandem Heart was explanted. A 12-lead
electrocardiogram (Figure 2) showed reduction of
the ST-segment elevations. A 2-dimensional
echocardiogram taken 6 days after admission
showed a left ventricular ejection fraction of 45%.
None of the 2-dimensional echocardiograms during
hospitalization showed evidence of right ventricular
involvement. The patient was discharged home
without any neurological deficit. At 8-month follow-
up, the patient is asymptomatic with a left
ventricular ejection fraction of 55%.
Discussion
Tako-tsubo cardiomyopathy is a unique, newly
recognized syndrome characterized by chest pain,
new electrocardiographic abnormalities mimicking
acute myocardial infarction, akinesis or dyskinesis
of apical and mid-left ventricular segments, and
absence of obstructive coronary artery disease.
Tako-tsubo cardiomyopathy is also called transient
left ventricular apical ballooning syndrome
(TLVABS), a potentially reversible form of cardiac
dysfunction. This syndrome was initially found in
Japanese patients and was named for the fishing
pot with a round bottom and narrow neck that is
used for trapping octopi in Japan (octopus is “tako”
and pot is “tsubo” in Japanese). Satoh et al. [1] were
among the first investigators to describe this
syndrome.
In a large proportion of persons with tako-tsubo
cardiomyopathy, there were significant psycho  -
logical stressors at the onset of symptoms (i.e.,
sudden accidents, death in the family, vigorous
excitation, or other exacerbating systemic disorders
such as cerebrovascular accident, epilepsy, bronchial
asthma, renal or urinary tract disease, an acute
abdomen, and noncardiac surgery or medical
procedures) [2]. Enhanced sympathetic activity is
thought to be one of the important mechanisms
underlying TLVABS. Excessive adrenergic discharge
has been demonstrated to cause transient spasm
of the epicardial vessels, producing myocyte injury
with subsequent ballooning of the myocardial apex
[3]. This is further supported by reports of a tako-
tsubo-like pattern in the endocrine crisis from
pheochromocytoma [4]. Interestingly, an inverted-
tako-tsubo pattern (ballooning of the base) rather
than apical ballooning has been described
commonly in pheochromocytoma [5-7]. Reversible
left ventricular dysfunction with apical hypokinesis
has also been described in hyperadrenergic states
such as hyperthyroidism [8, 9].
The clinical features of TLVABS were studied in
a systematic review of 28 series including 
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563 patients [10]. TLVABS was observed in 0.7-2.5%
of patients with suspected acute coronary
syndrome. It was predominantly observed in
postmenopausal women subsequent to a stressful
event. It affects women in 90.7% of cases, with
a mean age ranging from 62 to 76 years. The most
common presenting symptoms include chest pain
(83.4%) and dyspnea (20.4%) [10]. Initial
presentations with syncope, palpitations,
hypotension, ventricular fibrillation and cardiac
arrest have also been described [11]. Preceding
emotionally stressful events were recognized in
44% and physical stressors in 36.2% [10]. Common
electrocardiographic changes include ST-segment
elevation (71.1%), T-wave inversion (61.3%) and
pathological Q waves (31.1%) [10]. Transient QT
prolongation was consistently described in TLVABS
[10]. The mean/median QTc ranged from 445.8 to
542 ms. Electrocardiography does not allow reliable
differentiation between TLVABS and anterior ST-
segment myocardial infarction with enough
certainty to preclude coronary angiography. Cardiac
biomarkers were elevated in 85% of patients [10].
Coronary angiography showed completely normal
coronaries in 87.9% and noncritical luminal
stenoses in the other patients [10]. Left ventricular
function assessed by echocardiography, left
ventriculography or cardiac magnetic resonance
imaging typically showed dyskinesis of the left
ventricular apical or mid-ventricular segments with
a hyperkinetic basal region [10]. The mean left
ventricular ejection on admission ranged from 20%
to 49.4% and recovered over a period of 18 days on
average (range 7 to 37 days) [10]. Transient
intraventricular pressure gradients between the
apex and the base reflecting dynamic left
ventricular outflow tract obstruction have been
described in 16.4% [10]. Identification of these
clinical features has led to the proposal of Mayo
criteria for the diagnosis of tako-tsubo
cardiomyopathy [12].
Mayo criteria for the diagnosis of tako-tsubo
cardiomyopathy are 1) transient akinesis or
dyskinesis of the left ventricular apical and mid-
ventricular segments with regional wall-motion
abnormalities extending beyond a single epicardial
vascular distribution, 2) absence of obstructive
coronary disease or angiographic evidence of acute
plaque rupture, 3) new electrocardiographic
abnormalities (either ST-segment elevation or 
T-wave inversion), and absence of recent significant
head trauma, intracranial bleeding, pheochro  -
mocytoma, obstructive epicardial coronary artery
disease, myocarditis, and hypertrophic obstructive
cardiomyopathy [12]. 
Cardiomyopathy may result years after treatment
with radiation therapy [13] but has not been
implicated in the pathogenesis of tako-tsubo
cardiomyopathy. It is possible that prior radiation
contributed to the malignant course in this patient,
who had radiation therapy for breast cancer.
Chemotherapy has been implicated in the
pathogenesis of tako-tsubo cardiomyopathy [14, 15]
but was not administered to this patient.
A variety of serious complications have been
reported during the acute phase of tako-tsubo
cardiomyopathy [10]. These complications include
heart failure and pulmonary edema (15.9%),
cardiogenic shock (10.3%) and life-threatening
arrhythmias in 14.6%. Isolated cases of left
ventricular free wall rupture have also been
reported. The overall in-hospital mortality rate was
1.7%. Recurrence of the syndrome is rare (3.1%).
Supportive measures are the mainstay of
management during the acute phase of tako-tsubo
cardiomyopathy. There are no specific therapies that
lead to recovery from tako-tsubo cardiomyopathy.
Management of patients with this syndrome
includes medical management with aspirin, beta
blockers, and angiotensin-converting enzyme
inhibitors. Patients with severe congestive heart
failure will require diuretics, inotropic drugs, and
mechanical circulatory support if left ventricular
dysfunction is severe. Interim anticoagulation has
also been advised in patients with severe systolic
dysfunction to prevent left ventricular mural
thrombus formation. Severe left ventricular
dysfunction warranted the use of inotropic agents
in 23.6% of patients and hemodynamic support
with intra-aortic balloon-pump counterpulsation in
11.2% of patients [10]. The use of a TandemHeartTM
has not been previously reported. 
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